Poor blood sugar regulation and unhealthy triglyceride and lipoprotein levels often appear in lab tests well before an official diagnosis of type 2 diabetes. It is important to get tested for the risk of atherosclerotic cardiovascular disease and progression towards type 2 diabetes, conditions which can be deadly.
The complete CardioMetabolic panel measures risk of heart disease and diabetes. This new panel, which includes SpectraCell's advanced Lipoprotein Particle ProfileTM , reports several clinically relevant biomarkers in three areas: glycemic control, lipid metabolism and vascular inflammation. Each patient is also given a pre-diabetic risk score ranging from 1-8 depending on their results. The results of this panel of tests will allow our doctors to assess your risk factors and draw up an appropriate treatment plan.
Below are the key components of this comprehensive panel.